Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind Study to Determine Effect of Omalizumab Treatment in Patients With the Co-Morbid Conditions of Aspirin Exacerbated Respiratory Disease(AERD) and Allergic Asthma and Rhinitis.

NCT00286416 is registered in ClinicalTrials.gov with Scripps Clinic as lead sponsor.

NCT NCT00286416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00286416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind Study to Determine Effect of Omalizumab Treatment in Patients With the Co-Morbid Conditions of Aspirin Exacerbated Respiratory Disease(AERD) and Allergic Asthma and Rhinitis.
Lead sponsor
Scripps Clinic
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2006
Completion date
July 31, 2008
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis, asthma